Qiang Ding

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Top Venues

Nanomaterials (Basel, Switzerland)

Nature communications

Journal of experimental & clinical cancer research : CR

This page only lists publications with an associated author ORCID identifier.

Publications

Xinyu Tang, Xinrui Mao, Peiwen Ling, Muxin Yu, Hua Pan, Jiaming Wang, Mingduo Liu, Hong Pan, Wen Qiu, Nan Che, Kai Zhang, Feifan Bao, Hongwei Peng, Qiang Ding, Shui Wang, Wenbin Zhou
Glycolysis inhibition induces anti-tumor central memory CD8 + T cell differentiation upon combination with microwave ablation therapy. Nature communications 15 (1) (2024)
Yu-Zhou Huang, Ming-Yi Sang, Pei-Wen Xi, Ruo-Xi Xu, Meng-Yuan Cai, Zi-Wen Wang, Jianyi Zhao, Yi-Han Li, Ji-Fu Wei, Qiang Ding
FANCI Inhibition Induces PARP1 Redistribution to Enhance the Efficacy of PARP Inhibitors in Breast Cancer. Cancer research (2024)
Xinyu Tang, Xinrui Mao, Peiwen Ling, Muxin Yu, Hua Pan, Jiaming Wang, Mingduo Liu, Hong Pan, Wen Qiu, Nan Che, Kai Zhang, Feifan Bao, Hongwei Peng, Qiang Ding, Shui Wang, Wenbin Zhou
Glycolysis inhibition induces anti-tumor central memory CD8 + T cell differentiation upon combination with microwave ablation therapy. Nature communications 15 (1) (2024)
Handong Sun, Lishen Zhang, Zhonglin Wang, Danling Gu, Mengyan Zhu, Yun Cai, Lu Li, Jiaqi Tang, Bin Huang, Bakwatanisa Bosco, Ning Li, Lingxiang Wu, Wei Wu, Liangyu Li, Yuan Liang, Lin Luo, Quanzhong Liu, Yanhui Zhu, Jie Sun, Liang Shi, Tiansong Xia, Chuang Yang, Qitong Xu, Xue Han, Weiming Zhang, Jianxia Liu, Dong Meng, Hua Shao, Xiangxin Zheng, Shuqin Li, Hua Pan, Jing Ke, Wenying Jiang, Xiaolan Zhang, Xuedong Han, Jian Chu, Hongyin An, Juyan Ge, Chi Pan, Xiuxing Wang, Kening Li, Qiang-Hu Wang, Qiang Ding
Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer. Nature communications 14 (1) (2023)
Tian Xia, Xin-Yuan Dai, Ming-Yi Sang, Xu Zhang, Feng Xu, Jing Wu, Liang Shi, Ji-Fu Wei, Qiang Ding
IGF2BP2 Drives Cell Cycle Progression in Triple-Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A-Modified CDK6 Translation Initiation Process. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Xu Zhang, Liang Shi, Han-Dong Sun, Zi-Wen Wang, Feng Xu, Ji-Fu Wei, Qiang Ding
IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner. Clinical and translational medicine 13 (9) (2023)
Liang Shi, Jing Wu, Yue Hu, Xu Zhang, Zhi Li, Pei-Wen Xi, Ji-Fu Wei, Qiang Ding
Biomedical Indicators of Patients with Non-Puerperal Mastitis: A Retrospective Study. Nutrients 14 (22) (2022)
Haiyan Yang, Zhi Li, Zhangwei Wang, Xu Zhang, Xinyuan Dai, Guoren Zhou, Qiang Ding
Histocompatibility Minor 13 (HM13), targeted by miR-760, exerts oncogenic role in breast cancer by suppressing autophagy and activating PI3K-AKT-mTOR pathway. Cell death & disease 13 (8) (2022)
Qingyuan Wang, Zhizheng Zhang, Dehui Qiu, Xuanxiang Mao, Zhaoxi Zhou, Tiansong Xia, Jifu Wei, Qiang Ding, Xiaobo Zhang
LnNP@ZIF8 Smart System for In Situ NIR-II Ratiometric Imaging-Based Tumor Drug Resistance Evaluation. Nanomaterials (Basel, Switzerland) 12 (24) (2022)
Qingyuan Wang, Zhizheng Zhang, Dehui Qiu, Xuanxiang Mao, Zhaoxi Zhou, Tiansong Xia, Jifu Wei, Qiang Ding, Xiaobo Zhang
LnNP@ZIF8 Smart System for In Situ NIR-II Ratiometric Imaging-Based Tumor Drug Resistance Evaluation. Nanomaterials (Basel, Switzerland) 12 (24) (2022)
Qingyuan Wang, Zhizheng Zhang, Dehui Qiu, Xuanxiang Mao, Zhaoxi Zhou, Tiansong Xia, Jifu Wei, Qiang Ding, Xiaobo Zhang
LnNP@ZIF8 Smart System for In Situ NIR-II Ratiometric Imaging-Based Tumor Drug Resistance Evaluation. Nanomaterials (Basel, Switzerland) 12 (24) (2022)
Qingyuan Wang, Zhizheng Zhang, Dehui Qiu, Xuanxiang Mao, Zhaoxi Zhou, Tiansong Xia, Jifu Wei, Qiang Ding, Xiaobo Zhang
LnNP@ZIF8 Smart System for In Situ NIR-II Ratiometric Imaging-Based Tumor Drug Resistance Evaluation. Nanomaterials (Basel, Switzerland) 12 (24) (2022)
Zhi Li, Hai-Yan Yang, Xiao-Lan Zhang, Xu Zhang, Yu-Zhou Huang, Xin-Yuan Dai, Liang Shi, Guo-Ren Zhou, Ji-Fu Wei, Qiang Ding
Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Lin Cheng, Xu Zhang, Yu-Zhou Huang, Yu-Lan Zhu, Ling-Yun Xu, Zhi Li, Xin-Yuan Dai, Liang Shi, Xu-Jie Zhou, Ji-Fu Wei, Qiang Ding
Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway. Oncogenesis 10 (1) (2021)